About aescuvest
-
read full story
22.03.2020
#TakeBackControl
The coronavirus is spreading rapidly all over the world. Now is the time to get a grip on the global threat. In order to flatten the curve, fast reaction is essential.
-
read full story
10.03.2020
COVID 19 Makes Markets Stumble
It is still not clear how dangerous the coronavirus really is for those it infects. But one thing is already sure: the impending epidemic is shaking up the economy and financial markets.
-
read full story
05.03.2020
Is AI a Threat or an Opportunity for Healthcare?
Healthcare is one of the major success stories of our time, but it is also in crisis. Healthcare providers face rising demand, increasing delivery costs and workforce shortages, as well as the need to adapt to new ways of working that maximize the use of innovative technology to deliver better quality care.
-
read full story
28.02.2020
Where Equity Crowdfunding Fits Into An Investment Portfolio
Venture capital is no longer the exclusive preserve of the wealthy, says bestselling author Nathan Rose. Startups are building the economy of the future. They are disrupting old markets and finding new ways to solve problems. Wealthy investors have always been able to invest in these types of exciting opportunities and enjoy the potential for outsized returns in the event the companies achieve their ambitions.
-
read full story
28.02.2020
The Hunt for Capital
In its early days, the self-driving technology firm Cruise Automation went the crowdfunding route, raising a mere $200,000. In 2016, just two years after that first crowdfunding push, Cruise Automation was acquired by General Motors for a mind-blowing $1 billion in cash and stock, making the company the first billion-dollar exit for equity-based crowdfunding, a unicorn you can ride.
-
read full story
19.02.2020
Is Money All Around?
2019 saw a record-breaking aggregate deal value for the European venture landscape as alternative and international sources of capital flooded in. Venture fundraising has also hit a new peak.
-
read full story
04.02.2020
What We Can Learn From the Coronavirus Case
Are we facing an unprecedented public health threat? Are public authorities able to manage the outbreak of an epidemic disease? Do masks help? Should you avoid airports?
-
read full story
30.01.2020
European Health Catapult Open for New Applications
Start-ups, watch out: doors have been opened to enter the European Health Catapult Competition Vintage 2020. Catapult is EIT Health’s individualized training program and competition that aims to boost the development and visibility of high-potential European health start-ups.
-
read full story
24.01.2020
What Does “Prospectus-approved” Mean for an Investor?
On aescuvest.eu, investors become participants in the business chances of a start-up based on security investments. In order to issue and distribute shares Europe-wide, the start-up has to prepare a comprehensive offering document: the so-called prospectus has to be approved by a European financial authority before publishing, in this case by BaFin, Germany’s Federal Financial Supervisory Authority. What does this mean for the investors?
-
read full story
16.01.2020
When in San Francisco…
Health investors and entrepreneurs alike have a common place to travel to each January: California. And this is not due to the lack of sunshine that we usually experience in many regions of the northern hemisphere at this time of the year.
-
read full story
09.01.2020
The Three Pillars of Surge-on Medical’s Business Model
Just in case you are wondering how Surge-on Medical makes money, look no further. We do not solely rely on the unique surgical instruments we are developing. In fact, our patented platform technology enables us to have multiple revenue streams we would like to share with you. So, let’s take a look at Surge-on Medical’s business model that is built on three pillars, namely product sales, IP licenses and contract research.
-
read full story
19.12.2019
Why Is Surge-on Medical’s Technology Unique
With the regulatory recommendations to switch to cleanable and reusable surgical instruments, several medical companies find themselves struggling to adapt. Most of the already established medical companies supply robust and stiff instruments, while others offer a few complex steering systems that must be discarded after being used a couple of times.
Get notified
of new campaigns and news.
We do not sell or share your data to third parties. View our Privacy notice